Valirx plc (VAL) RNS Announcements

Date	Time	Date	TitleTitle (filtered)	Source
06/07/18	17:42:41	6 Jul 2018	Notice of GM	Notice of GM	RNS
14/06/18	08:00:02	14 Jun 2018	VAL401 Update	VAL401 Update	RNS
24/05/18	10:00:38	24 May 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
11/05/18	15:56:37	11 May 2018	Holding(s) in Company	Holding(s) in Company	RNS
04/05/18	17:40:35	4 May 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
04/05/18	17:35:23	4 May 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
04/05/18	17:01:36	4 May 2018	Placing and grant of warrants	Placing and grant of warrants	RNS
26/04/18	15:05:43	26 Apr 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
26/04/18	15:00:14	26 Apr 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
25/04/18	17:40:54	25 Apr 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
25/04/18	17:35:39	25 Apr 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
25/04/18	08:00:08	25 Apr 2018	EU Patent Grant for Therapeutic Compound, VAL201	EU Patent Grant for Therapeutic Compound, VAL201	RNS
19/04/18	08:00:02	19 Apr 2018	GENEICE & VAL101 Update	GENEICE & VAL101 Update	RNS
12/04/18	08:00:06	12 Apr 2018	Notice of AGM	Notice of AGM	RNS
10/04/18	08:00:03	10 Apr 2018	Final Results	Final Results	RNS
20/03/18	07:00:03	20 Mar 2018	US Patent Grant for Therapeutic Compound, VAL201	US Patent Grant for Therapeutic Compound, VAL201	RNS
19/03/18	07:00:06	19 Mar 2018	Holding(s) in Company	Holding(s) in Company	RNS
16/03/18	15:01:42	16 Mar 2018	Appointment of Broker	Appointment of Broker	RNS
02/03/18	11:01:57	2 Mar 2018	Statement re broker	Statement re broker	RNS
09/02/18	11:57:17	9 Feb 2018	Issue of options and directors dealings	Issue of options and directors dealings	RNS
02/02/18	16:26:56	2 Feb 2018	Holding(s) in Company	Holding(s) in Company	RNS
25/01/18	12:06:21	25 Jan 2018	Holding(s) in Company	Holding(s) in Company	RNS
23/01/18	15:30:15	23 Jan 2018	Holding(s) in Company	Holding(s) in Company	RNS
16/01/18	07:00:03	16 Jan 2018	ValiSeek Clinical Update (VAL401)	ValiSeek Clinical Update (VAL401)	RNS
11/01/18	07:00:03	11 Jan 2018	US Patent Notice of Allowance for Compound VAL201	US Patent Notice of Allowance for Compound VAL201	RNS
04/01/18	14:29:07	4 Jan 2018	Holding(s) in Company	Holding(s) in Company	RNS
03/01/18	07:00:02	3 Jan 2018	Exercise of Warrants and Issue of Equity	Exercise of Warrants and Issue of Equity	RNS
27/12/17	12:54:59	27 Dec 2017	Final Loan Note Conversion and Issue of Equity	Final Loan Note Conversion and Issue of Equity	RNS
22/12/17	07:00:03	22 Dec 2017	Issue of Equity	Issue of Equity	RNS
21/12/17	09:16:26	21 Dec 2017	Result of General Meeting	Result of General Meeting	RNS
20/12/17	15:58:32	20 Dec 2017	Warrant Exercise	Warrant Exercise	RNS
20/12/17	15:03:20	20 Dec 2017	Warrant Exercise	Warrant Exercise	RNS
18/12/17	08:45:02	18 Dec 2017	Warrant Exercise	Warrant Exercise	RNS
18/12/17	07:00:03	18 Dec 2017	re: VAL201 Clinical Trials	re: VAL201 Clinical Trials	RNS
15/12/17	07:00:03	15 Dec 2017	Exercise of Warrants and Issue of Equity	Exercise of Warrants and Issue of Equity	RNS
12/12/17	07:00:04	12 Dec 2017	ValiSeek Clinical Development Update	ValiSeek Clinical Development Update	RNS
11/12/17	15:48:22	11 Dec 2017	Loan Note Conversion and Issue of Equity	Loan Note Conversion and Issue of Equity	RNS
06/12/17	07:00:03	6 Dec 2017	Shareholder Circular and Notice of General Meeting	Shareholder Circular and Notice of General Meeting	RNS
30/11/17	14:38:19	30 Nov 2017	Issue of Equity	Issue of Equity	RNS
20/11/17	11:23:08	20 Nov 2017	Holding(s) in Company	Holding(s) in Company	RNS
15/11/17	16:37:35	15 Nov 2017	Yorkville CLN Conversion	Yorkville CLN Conversion	RNS
11/10/17	08:00:02	11 Oct 2017	Notification of US Patent Allowance	Notification of US Patent Allowance	RNS
05/10/17	08:00:05	5 Oct 2017	Holding(s) in Company	Holding(s) in Company	RNS
02/10/17	08:00:03	2 Oct 2017	Total Voting Rights	Total Voting Rights	RNS
28/09/17	08:00:02	28 Sept 2017	ValiSeek Clinical Development Update	ValiSeek Clinical Development Update	RNS
27/09/17	16:32:56	27 Sept 2017	Holding(s) in Company	Holding(s) in Company	RNS
26/09/17	08:00:05	26 Sept 2017	Half-year Report	Half-year Report	RNS
20/09/17	16:18:08	20 Sept 2017	VAL201 update	VAL201 update	RNS
19/09/17	08:00:05	19 Sept 2017	Issue of Equity	Issue of Equity	RNS
13/09/17	10:34:00	13 Sept 2017	Hardman Research: GeneICE and VAL101 progress	Hardman Research: GeneICE and VAL101 progress	RNS

Showing 401–450 of 582 announcements

Date	Time	Date	TitleTitle (filtered)	Source
06/07/18	17:42:41	6 Jul 2018	Notice of GM	Notice of GM	RNS
14/06/18	08:00:02	14 Jun 2018	VAL401 Update	VAL401 Update	RNS
24/05/18	10:00:38	24 May 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
11/05/18	15:56:37	11 May 2018	Holding(s) in Company	Holding(s) in Company	RNS
04/05/18	17:40:35	4 May 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
04/05/18	17:35:23	4 May 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
04/05/18	17:01:36	4 May 2018	Placing and grant of warrants	Placing and grant of warrants	RNS
26/04/18	15:05:43	26 Apr 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
26/04/18	15:00:14	26 Apr 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
25/04/18	17:40:54	25 Apr 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
25/04/18	17:35:39	25 Apr 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
25/04/18	08:00:08	25 Apr 2018	EU Patent Grant for Therapeutic Compound, VAL201	EU Patent Grant for Therapeutic Compound, VAL201	RNS
19/04/18	08:00:02	19 Apr 2018	GENEICE & VAL101 Update	GENEICE & VAL101 Update	RNS
12/04/18	08:00:06	12 Apr 2018	Notice of AGM	Notice of AGM	RNS
10/04/18	08:00:03	10 Apr 2018	Final Results	Final Results	RNS
20/03/18	07:00:03	20 Mar 2018	US Patent Grant for Therapeutic Compound, VAL201	US Patent Grant for Therapeutic Compound, VAL201	RNS
19/03/18	07:00:06	19 Mar 2018	Holding(s) in Company	Holding(s) in Company	RNS
16/03/18	15:01:42	16 Mar 2018	Appointment of Broker	Appointment of Broker	RNS
02/03/18	11:01:57	2 Mar 2018	Statement re broker	Statement re broker	RNS
09/02/18	11:57:17	9 Feb 2018	Issue of options and directors dealings	Issue of options and directors dealings	RNS
02/02/18	16:26:56	2 Feb 2018	Holding(s) in Company	Holding(s) in Company	RNS
25/01/18	12:06:21	25 Jan 2018	Holding(s) in Company	Holding(s) in Company	RNS
23/01/18	15:30:15	23 Jan 2018	Holding(s) in Company	Holding(s) in Company	RNS
16/01/18	07:00:03	16 Jan 2018	ValiSeek Clinical Update (VAL401)	ValiSeek Clinical Update (VAL401)	RNS
11/01/18	07:00:03	11 Jan 2018	US Patent Notice of Allowance for Compound VAL201	US Patent Notice of Allowance for Compound VAL201	RNS
04/01/18	14:29:07	4 Jan 2018	Holding(s) in Company	Holding(s) in Company	RNS
03/01/18	07:00:02	3 Jan 2018	Exercise of Warrants and Issue of Equity	Exercise of Warrants and Issue of Equity	RNS
27/12/17	12:54:59	27 Dec 2017	Final Loan Note Conversion and Issue of Equity	Final Loan Note Conversion and Issue of Equity	RNS
22/12/17	07:00:03	22 Dec 2017	Issue of Equity	Issue of Equity	RNS
21/12/17	09:16:26	21 Dec 2017	Result of General Meeting	Result of General Meeting	RNS
20/12/17	15:58:32	20 Dec 2017	Warrant Exercise	Warrant Exercise	RNS
20/12/17	15:03:20	20 Dec 2017	Warrant Exercise	Warrant Exercise	RNS
18/12/17	08:45:02	18 Dec 2017	Warrant Exercise	Warrant Exercise	RNS
18/12/17	07:00:03	18 Dec 2017	re: VAL201 Clinical Trials	re: VAL201 Clinical Trials	RNS
15/12/17	07:00:03	15 Dec 2017	Exercise of Warrants and Issue of Equity	Exercise of Warrants and Issue of Equity	RNS
12/12/17	07:00:04	12 Dec 2017	ValiSeek Clinical Development Update	ValiSeek Clinical Development Update	RNS
11/12/17	15:48:22	11 Dec 2017	Loan Note Conversion and Issue of Equity	Loan Note Conversion and Issue of Equity	RNS
06/12/17	07:00:03	6 Dec 2017	Shareholder Circular and Notice of General Meeting	Shareholder Circular and Notice of General Meeting	RNS
30/11/17	14:38:19	30 Nov 2017	Issue of Equity	Issue of Equity	RNS
20/11/17	11:23:08	20 Nov 2017	Holding(s) in Company	Holding(s) in Company	RNS
15/11/17	16:37:35	15 Nov 2017	Yorkville CLN Conversion	Yorkville CLN Conversion	RNS
11/10/17	08:00:02	11 Oct 2017	Notification of US Patent Allowance	Notification of US Patent Allowance	RNS
05/10/17	08:00:05	5 Oct 2017	Holding(s) in Company	Holding(s) in Company	RNS
02/10/17	08:00:03	2 Oct 2017	Total Voting Rights	Total Voting Rights	RNS
28/09/17	08:00:02	28 Sept 2017	ValiSeek Clinical Development Update	ValiSeek Clinical Development Update	RNS
27/09/17	16:32:56	27 Sept 2017	Holding(s) in Company	Holding(s) in Company	RNS
26/09/17	08:00:05	26 Sept 2017	Half-year Report	Half-year Report	RNS
20/09/17	16:18:08	20 Sept 2017	VAL201 update	VAL201 update	RNS
19/09/17	08:00:05	19 Sept 2017	Issue of Equity	Issue of Equity	RNS
13/09/17	10:34:00	13 Sept 2017	Hardman Research: GeneICE and VAL101 progress	Hardman Research: GeneICE and VAL101 progress	RNS

Showing 401–450 of 582 announcements

Date	Time	Date	TitleTitle (filtered)	Source
06/07/18	17:42:41	6 Jul 2018	Notice of GM	Notice of GM	RNS
14/06/18	08:00:02	14 Jun 2018	VAL401 Update	VAL401 Update	RNS
24/05/18	10:00:38	24 May 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
11/05/18	15:56:37	11 May 2018	Holding(s) in Company	Holding(s) in Company	RNS
04/05/18	17:40:35	4 May 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
04/05/18	17:35:23	4 May 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
04/05/18	17:01:36	4 May 2018	Placing and grant of warrants	Placing and grant of warrants	RNS
26/04/18	15:05:43	26 Apr 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
26/04/18	15:00:14	26 Apr 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
25/04/18	17:40:54	25 Apr 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
25/04/18	17:35:39	25 Apr 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
25/04/18	08:00:08	25 Apr 2018	EU Patent Grant for Therapeutic Compound, VAL201	EU Patent Grant for Therapeutic Compound, VAL201	RNS
19/04/18	08:00:02	19 Apr 2018	GENEICE & VAL101 Update	GENEICE & VAL101 Update	RNS
12/04/18	08:00:06	12 Apr 2018	Notice of AGM	Notice of AGM	RNS
10/04/18	08:00:03	10 Apr 2018	Final Results	Final Results	RNS
20/03/18	07:00:03	20 Mar 2018	US Patent Grant for Therapeutic Compound, VAL201	US Patent Grant for Therapeutic Compound, VAL201	RNS
19/03/18	07:00:06	19 Mar 2018	Holding(s) in Company	Holding(s) in Company	RNS
16/03/18	15:01:42	16 Mar 2018	Appointment of Broker	Appointment of Broker	RNS
02/03/18	11:01:57	2 Mar 2018	Statement re broker	Statement re broker	RNS
09/02/18	11:57:17	9 Feb 2018	Issue of options and directors dealings	Issue of options and directors dealings	RNS
02/02/18	16:26:56	2 Feb 2018	Holding(s) in Company	Holding(s) in Company	RNS
25/01/18	12:06:21	25 Jan 2018	Holding(s) in Company	Holding(s) in Company	RNS
23/01/18	15:30:15	23 Jan 2018	Holding(s) in Company	Holding(s) in Company	RNS
16/01/18	07:00:03	16 Jan 2018	ValiSeek Clinical Update (VAL401)	ValiSeek Clinical Update (VAL401)	RNS
11/01/18	07:00:03	11 Jan 2018	US Patent Notice of Allowance for Compound VAL201	US Patent Notice of Allowance for Compound VAL201	RNS
04/01/18	14:29:07	4 Jan 2018	Holding(s) in Company	Holding(s) in Company	RNS
03/01/18	07:00:02	3 Jan 2018	Exercise of Warrants and Issue of Equity	Exercise of Warrants and Issue of Equity	RNS
27/12/17	12:54:59	27 Dec 2017	Final Loan Note Conversion and Issue of Equity	Final Loan Note Conversion and Issue of Equity	RNS
22/12/17	07:00:03	22 Dec 2017	Issue of Equity	Issue of Equity	RNS
21/12/17	09:16:26	21 Dec 2017	Result of General Meeting	Result of General Meeting	RNS
20/12/17	15:58:32	20 Dec 2017	Warrant Exercise	Warrant Exercise	RNS
20/12/17	15:03:20	20 Dec 2017	Warrant Exercise	Warrant Exercise	RNS
18/12/17	08:45:02	18 Dec 2017	Warrant Exercise	Warrant Exercise	RNS
18/12/17	07:00:03	18 Dec 2017	re: VAL201 Clinical Trials	re: VAL201 Clinical Trials	RNS
15/12/17	07:00:03	15 Dec 2017	Exercise of Warrants and Issue of Equity	Exercise of Warrants and Issue of Equity	RNS
12/12/17	07:00:04	12 Dec 2017	ValiSeek Clinical Development Update	ValiSeek Clinical Development Update	RNS
11/12/17	15:48:22	11 Dec 2017	Loan Note Conversion and Issue of Equity	Loan Note Conversion and Issue of Equity	RNS
06/12/17	07:00:03	6 Dec 2017	Shareholder Circular and Notice of General Meeting	Shareholder Circular and Notice of General Meeting	RNS
30/11/17	14:38:19	30 Nov 2017	Issue of Equity	Issue of Equity	RNS
20/11/17	11:23:08	20 Nov 2017	Holding(s) in Company	Holding(s) in Company	RNS
15/11/17	16:37:35	15 Nov 2017	Yorkville CLN Conversion	Yorkville CLN Conversion	RNS
11/10/17	08:00:02	11 Oct 2017	Notification of US Patent Allowance	Notification of US Patent Allowance	RNS
05/10/17	08:00:05	5 Oct 2017	Holding(s) in Company	Holding(s) in Company	RNS
02/10/17	08:00:03	2 Oct 2017	Total Voting Rights	Total Voting Rights	RNS
28/09/17	08:00:02	28 Sept 2017	ValiSeek Clinical Development Update	ValiSeek Clinical Development Update	RNS
27/09/17	16:32:56	27 Sept 2017	Holding(s) in Company	Holding(s) in Company	RNS
26/09/17	08:00:05	26 Sept 2017	Half-year Report	Half-year Report	RNS
20/09/17	16:18:08	20 Sept 2017	VAL201 update	VAL201 update	RNS
19/09/17	08:00:05	19 Sept 2017	Issue of Equity	Issue of Equity	RNS
13/09/17	10:34:00	13 Sept 2017	Hardman Research: GeneICE and VAL101 progress	Hardman Research: GeneICE and VAL101 progress	RNS

Showing 401–450 of 582 announcements

Date	Time	Date	TitleTitle (filtered)	Source
06/07/18	17:42:41	6 Jul 2018	Notice of GM	Notice of GM	RNS
14/06/18	08:00:02	14 Jun 2018	VAL401 Update	VAL401 Update	RNS
24/05/18	10:00:38	24 May 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
11/05/18	15:56:37	11 May 2018	Holding(s) in Company	Holding(s) in Company	RNS
04/05/18	17:40:35	4 May 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
04/05/18	17:35:23	4 May 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
04/05/18	17:01:36	4 May 2018	Placing and grant of warrants	Placing and grant of warrants	RNS
26/04/18	15:05:43	26 Apr 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
26/04/18	15:00:14	26 Apr 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
25/04/18	17:40:54	25 Apr 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
25/04/18	17:35:39	25 Apr 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
25/04/18	08:00:08	25 Apr 2018	EU Patent Grant for Therapeutic Compound, VAL201	EU Patent Grant for Therapeutic Compound, VAL201	RNS
19/04/18	08:00:02	19 Apr 2018	GENEICE & VAL101 Update	GENEICE & VAL101 Update	RNS
12/04/18	08:00:06	12 Apr 2018	Notice of AGM	Notice of AGM	RNS
10/04/18	08:00:03	10 Apr 2018	Final Results	Final Results	RNS
20/03/18	07:00:03	20 Mar 2018	US Patent Grant for Therapeutic Compound, VAL201	US Patent Grant for Therapeutic Compound, VAL201	RNS
19/03/18	07:00:06	19 Mar 2018	Holding(s) in Company	Holding(s) in Company	RNS
16/03/18	15:01:42	16 Mar 2018	Appointment of Broker	Appointment of Broker	RNS
02/03/18	11:01:57	2 Mar 2018	Statement re broker	Statement re broker	RNS
09/02/18	11:57:17	9 Feb 2018	Issue of options and directors dealings	Issue of options and directors dealings	RNS
02/02/18	16:26:56	2 Feb 2018	Holding(s) in Company	Holding(s) in Company	RNS
25/01/18	12:06:21	25 Jan 2018	Holding(s) in Company	Holding(s) in Company	RNS
23/01/18	15:30:15	23 Jan 2018	Holding(s) in Company	Holding(s) in Company	RNS
16/01/18	07:00:03	16 Jan 2018	ValiSeek Clinical Update (VAL401)	ValiSeek Clinical Update (VAL401)	RNS
11/01/18	07:00:03	11 Jan 2018	US Patent Notice of Allowance for Compound VAL201	US Patent Notice of Allowance for Compound VAL201	RNS
04/01/18	14:29:07	4 Jan 2018	Holding(s) in Company	Holding(s) in Company	RNS
03/01/18	07:00:02	3 Jan 2018	Exercise of Warrants and Issue of Equity	Exercise of Warrants and Issue of Equity	RNS
27/12/17	12:54:59	27 Dec 2017	Final Loan Note Conversion and Issue of Equity	Final Loan Note Conversion and Issue of Equity	RNS
22/12/17	07:00:03	22 Dec 2017	Issue of Equity	Issue of Equity	RNS
21/12/17	09:16:26	21 Dec 2017	Result of General Meeting	Result of General Meeting	RNS
20/12/17	15:58:32	20 Dec 2017	Warrant Exercise	Warrant Exercise	RNS
20/12/17	15:03:20	20 Dec 2017	Warrant Exercise	Warrant Exercise	RNS
18/12/17	08:45:02	18 Dec 2017	Warrant Exercise	Warrant Exercise	RNS
18/12/17	07:00:03	18 Dec 2017	re: VAL201 Clinical Trials	re: VAL201 Clinical Trials	RNS
15/12/17	07:00:03	15 Dec 2017	Exercise of Warrants and Issue of Equity	Exercise of Warrants and Issue of Equity	RNS
12/12/17	07:00:04	12 Dec 2017	ValiSeek Clinical Development Update	ValiSeek Clinical Development Update	RNS
11/12/17	15:48:22	11 Dec 2017	Loan Note Conversion and Issue of Equity	Loan Note Conversion and Issue of Equity	RNS
06/12/17	07:00:03	6 Dec 2017	Shareholder Circular and Notice of General Meeting	Shareholder Circular and Notice of General Meeting	RNS
30/11/17	14:38:19	30 Nov 2017	Issue of Equity	Issue of Equity	RNS
20/11/17	11:23:08	20 Nov 2017	Holding(s) in Company	Holding(s) in Company	RNS
15/11/17	16:37:35	15 Nov 2017	Yorkville CLN Conversion	Yorkville CLN Conversion	RNS
11/10/17	08:00:02	11 Oct 2017	Notification of US Patent Allowance	Notification of US Patent Allowance	RNS
05/10/17	08:00:05	5 Oct 2017	Holding(s) in Company	Holding(s) in Company	RNS
02/10/17	08:00:03	2 Oct 2017	Total Voting Rights	Total Voting Rights	RNS
28/09/17	08:00:02	28 Sept 2017	ValiSeek Clinical Development Update	ValiSeek Clinical Development Update	RNS
27/09/17	16:32:56	27 Sept 2017	Holding(s) in Company	Holding(s) in Company	RNS
26/09/17	08:00:05	26 Sept 2017	Half-year Report	Half-year Report	RNS
20/09/17	16:18:08	20 Sept 2017	VAL201 update	VAL201 update	RNS
19/09/17	08:00:05	19 Sept 2017	Issue of Equity	Issue of Equity	RNS
13/09/17	10:34:00	13 Sept 2017	Hardman Research: GeneICE and VAL101 progress	Hardman Research: GeneICE and VAL101 progress	RNS

Showing 401–450 of 582 announcements

Valirx plc RNS

Valirx plc RNS